GW&K Investment Management LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 26,782 shares of the company’s stock, valued at approximately $5,244,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALAB. Vanguard Group Inc. increased its position in Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. Rafferty Asset Management LLC purchased a new stake in shares of Astera Labs in the 3rd quarter worth approximately $209,599,000. 1832 Asset Management L.P. lifted its position in shares of Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after purchasing an additional 929,600 shares during the period. Holocene Advisors LP bought a new position in shares of Astera Labs during the second quarter valued at approximately $55,827,000. Finally, State Street Corp increased its holdings in Astera Labs by 39.3% during the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after buying an additional 604,363 shares during the period. 60.47% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
ALAB has been the subject of a number of recent research reports. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Morgan Stanley restated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Loop Capital assumed coverage on Astera Labs in a research report on Thursday. They set a “buy” rating and a $250.00 price objective on the stock. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $195.89.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. The trade was a 6.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 216,792 shares of company stock valued at $26,777,569 over the last quarter. Insiders own 12.50% of the company’s stock.
Astera Labs Stock Performance
Shares of ALAB stock opened at $119.20 on Friday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm has a market capitalization of $20.29 billion, a price-to-earnings ratio of 97.70, a PEG ratio of 2.36 and a beta of 1.74. The stock’s 50-day simple moving average is $152.88 and its 200-day simple moving average is $170.06.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period last year, the firm posted $0.37 EPS. Astera Labs’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Loop Capital initiated coverage with a Buy and a $250 price target, highlighting Astera’s role in AI datacenter connectivity and providing a sizable upside thesis for the stock. Read More.
- Positive Sentiment: An initiation piece argues Astera can still be an “AI winner,” reinforcing investor interest in its connectivity chips and software for high‑bandwidth servers. Read More.
- Positive Sentiment: Recent quarterly results showed a revenue and EPS beat and management set modest Q1 EPS guidance, supporting the growth story behind multiple analyst Buy ratings. Read More.
- Neutral Sentiment: Analysts and outlets flag that ALAB is trading at a premium valuation and faces stiff competition — that supports a cautious stance despite strong end‑market demand. Read More.
- Neutral Sentiment: Coverage pieces note mixed share‑price signals vs growth expectations, leaving valuation and timing as the primary debate among investors. Read More.
- Neutral Sentiment: Several writeups describe a shifting investment narrative as analysts update models — positive for long‑term thesis but creating short‑term opinion dispersion. Read More.
- Negative Sentiment: Coverage reports that a margin “reset” tied to an Amazon AI deal could compress near‑term margins, raising execution and profitability concerns for investors focused on margin expansion. Read More.
- Negative Sentiment: Insider selling: Astera’s General Counsel sold 10,000 shares (disclosed early March), which some investors interpret as a near‑term negative signal even though insiders still hold large stakes. Read More.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
